Biotech leader Kiniksa stock is poised to hit a new buy point after shares soared 25% in response to better-than-expected ...

Analysts: slightly positive tone, with repeated emphasis on "strong quarter" and multiple follow-ups probing durability of commercial drivers (DTC, co-pay, first recurrence expansion) and KPL-387 ...

LONDON, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is gearing up to announce its quarterly earnings on Tuesday, 2024-10-29. Here's a quick overview of what investors should know before the release. Analysts are ...

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is preparing to release its quarterly earnings on Tuesday, 2025-10-28. Here's a brief overview of what investors should keep in mind before the announcement.

Earnings Call Insights: Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Sanj Patel, CEO, stated that "ARCALYST revenue continues to grow, driven by the expanding adoption of IL-1 alpha and ...

Kiniksa Pharmaceuticals International, plc (KNSA) shares soared 5.4% in the last trading session to close at $62.41. The move was backed by solid volume with far more shares changing hands than in a ...

At the time of writing, Kiniksa Pharmaceuticals (KNSA) stock is trading at $62 per share - up ~120% on a 12-month basis and up nearly 350% on a 5-year basis - while its market cap valuation is $4.77bn ...

Kiniksa Pharmaceuticals (NASDAQ:KNSA) is set to give its latest quarterly earnings report on Tuesday, 2026-02-24. Here's what investors need to know before the announcement. Analysts estimate that ...

Explore the exciting world of Kiniksa Pharmaceuticals (NASDAQ: KNSA) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market ...